Safety and Efficacy of the Early Introduction of Everolimus With Reduced-Exposure Cyclosporine A in De Novo Kidney Recipients-Reference-Cited by-同舟云学术

Safety and Efficacy of the Early Introduction of Everolimus With Reduced-Exposure Cyclosporine A in De Novo Kidney Recipients

Published:2015-01 Issue:1 Volume:99 Page:180-186
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Oh Chang-Kwon,Huh Kyu Ha,Ha Jongwon,Kim Yeong Hoon,Kim Yong-Lim,Kim Yu Seun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference23 articles.

1. Long-term kidney transplant survival.;Hariharan;Am J Kidney Dis,2001

2. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies Am J T;Meier-Kriesche;ransplant,2004

3. The natural history of chronic allograft nephropathy.;Nankivell;N Engl J Med,2003

4. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology.;Nankivell;Transplantation,2004

5. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.;Weir;Kidney Int,2001

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcineurin Inhibitors Nephrotoxicity Prevention Strategies With Stress on Belatacept-Based Rescue Immunotherapy: A Review of the Current Evidence;Transplantation Proceedings;2021-06

2. Real-World Efficacy and Safety of Everolimus with Low Dose Tacrolimus in Liver Transplantation Recipients;Korean Journal of Clinical Pharmacy;2021-03-31

3. Comparison of two strategies based on mammalian target of rapamycin inhibitors in secondary prevention of non‐melanoma skin cancer after kidney transplantation, a pilot study;Clinical Transplantation;2021-01-20

4. Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: A prospective cohort study;Asian Journal of Surgery;2020-06

5. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients;Cochrane Database of Systematic Reviews;2019-12-16